The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
The global DPT Vaccines market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6619.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
Report Scope
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Age, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Age, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Age, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 DPT Vaccines Market Overview
1.1 Product Overview and Scope of DPT Vaccines
1.2 DPT Vaccines Segment by Type
1.2.1 Global DPT Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 DPT Vaccines Segment by Age
1.3.1 Global DPT Vaccines Market Value by Age: (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global DPT Vaccines Market Size Estimates and Forecasts
1.4.1 Global DPT Vaccines Revenue 2019-2030
1.4.2 Global DPT Vaccines Sales 2019-2030
1.4.3 Global DPT Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DPT Vaccines Market Competition by Manufacturers
2.1 Global DPT Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global DPT Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global DPT Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global DPT Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DPT Vaccines, Product Type & Application
2.7 DPT Vaccines Market Competitive Situation and Trends
2.7.1 DPT Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DPT Vaccines Players Market Share by Revenue
2.7.3 Global DPT Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DPT Vaccines Retrospective Market Scenario by Region
3.1 Global DPT Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DPT Vaccines Global DPT Vaccines Sales by Region: 2019-2030
3.2.1 Global DPT Vaccines Sales by Region: 2019-2024
3.2.2 Global DPT Vaccines Sales by Region: 2025-2030
3.3 Global DPT Vaccines Global DPT Vaccines Revenue by Region: 2019-2030
3.3.1 Global DPT Vaccines Revenue by Region: 2019-2024
3.3.2 Global DPT Vaccines Revenue by Region: 2025-2030
3.4 North America DPT Vaccines Market Facts & Figures by Country
3.4.1 North America DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DPT Vaccines Sales by Country (2019-2030)
3.4.3 North America DPT Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe DPT Vaccines Market Facts & Figures by Country
3.5.1 Europe DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DPT Vaccines Sales by Country (2019-2030)
3.5.3 Europe DPT Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DPT Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DPT Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific DPT Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DPT Vaccines Market Facts & Figures by Country
3.7.1 Latin America DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DPT Vaccines Sales by Country (2019-2030)
3.7.3 Latin America DPT Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DPT Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DPT Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DPT Vaccines Sales by Type (2019-2030)
4.1.1 Global DPT Vaccines Sales by Type (2019-2024)
4.1.2 Global DPT Vaccines Sales by Type (2025-2030)
4.1.3 Global DPT Vaccines Sales Market Share by Type (2019-2030)
4.2 Global DPT Vaccines Revenue by Type (2019-2030)
4.2.1 Global DPT Vaccines Revenue by Type (2019-2024)
4.2.2 Global DPT Vaccines Revenue by Type (2025-2030)
4.2.3 Global DPT Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global DPT Vaccines Price by Type (2019-2030)
5 Segment by Age
5.1 Global DPT Vaccines Sales by Age (2019-2030)
5.1.1 Global DPT Vaccines Sales by Age (2019-2024)
5.1.2 Global DPT Vaccines Sales by Age (2025-2030)
5.1.3 Global DPT Vaccines Sales Market Share by Age (2019-2030)
5.2 Global DPT Vaccines Revenue by Age (2019-2030)
5.2.1 Global DPT Vaccines Revenue by Age (2019-2024)
5.2.2 Global DPT Vaccines Revenue by Age (2025-2030)
5.2.3 Global DPT Vaccines Revenue Market Share by Age (2019-2030)
5.3 Global DPT Vaccines Price by Age (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK DPT Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Corporation Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics DPT Vaccines Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Corporation Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.6.1 Chengdu Institute of Biological Products Corporation Information
6.6.2 Chengdu Institute of Biological Products Description and Business Overview
6.6.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Corporation Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DPT Vaccines Industry Chain Analysis
7.2 DPT Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DPT Vaccines Production Mode & Process
7.4 DPT Vaccines Sales and Marketing
7.4.1 DPT Vaccines Sales Channels
7.4.2 DPT Vaccines Distributors
7.5 DPT Vaccines Customers
8 DPT Vaccines Market Dynamics
8.1 DPT Vaccines Industry Trends
8.2 DPT Vaccines Market Drivers
8.3 DPT Vaccines Market Challenges
8.4 DPT Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
*If Applicable.